A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer

Purpose Nedaplatin is a cisplatin derivative, which has similar activity to cisplatin in non-small-cell lung cancer (NSCLC) when combined with vindesine, and causes less nausea/vomiting and nephrotoxicity compared with cisplatin. The aim of this study was to evaluate the efficacy and safety of combi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer chemotherapy and pharmacology 2012-10, Vol.70 (4), p.531-537
Hauptverfasser:	Teramoto, Koji, Asada, Yoshikuni, Ozaki, Yoshitomo, Suzumura, Yuji, Nakano, Yasutaka, Sawai, Satoru, Tezuka, Noriaki, Inoue, Shuhei, Fujino, Shozo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Cancer Research Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology Dermatology Female Humans Lung cancer Lung Neoplasms - drug therapy Lung Neoplasms - mortality Lung Neoplasms - pathology Male Medical sciences Medicine Medicine & Public Health Middle Aged Neoplasm Staging Oncology Organoplatinum Compounds - administration & dosage Organoplatinum Compounds - adverse effects Original Article Pharmacology. Drug treatments Pharmacology/Toxicology Pneumology Taxoids - administration & dosage Taxoids - adverse effects Tumors of the respiratory system and mediastinum Tumors of the skin and soft tissue. Premalignant lesions
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!